St. Ives

Description

ST. IVES SOLUTIONS ACNE CONTROL SPOT TREATMENT is a topical lotion formulated with salicylic acid as its active ingredient. This product is designed to target and treat acne lesions effectively. The formulation leverages the properties of salicylic acid, known for its ability to penetrate pores and facilitate the exfoliation of dead skin cells, thereby helping to reduce the occurrence of acne.

Uses and Indications

This drug is indicated for the management of acne. It helps prevent the formation of new acne pimples and acne blemishes.

Dosage and Administration

Healthcare professionals are advised to cleanse the skin thoroughly prior to the application of the product. The affected area should be covered with a thin layer of the product one to three times daily.

Initial treatment should begin with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients that the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

In cases of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay. It is crucial for healthcare providers to emphasize the importance of these precautions to ensure patient safety and effective treatment outcomes.

Side Effects

Patients should be aware that this product is intended for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that only one topical acne medication be used at a time to minimize adverse reactions.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one product at a time to minimize the potential for adverse effects. If skin irritation occurs, the user should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of St. Ives (solutions acne control spot treatment). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or directed by a healthcare professional. Should any bothersome dryness or peeling occur, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Pregnant women are advised to avoid using this product and should consult a healthcare provider for alternatives. Additionally, the use of topical salicylic acid should be limited during pregnancy, and healthcare professionals should be consulted for guidance on appropriate treatment options.

Lactation

The safety of this product during lactation has not been established. Caution should be exercised when using this product in nursing mothers. There is a potential for excretion in breast milk; therefore, the use of this product should be carefully considered in nursing mothers, weighing the benefits against potential risks to the infant.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a configuration that includes menthol as an active ingredient. Healthcare professionals are advised to monitor for any signs of discomfort in patients using this product; should discomfort occur, usage should be discontinued immediately.

For optimal storage, the product should be kept at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F). It is essential to protect the product from excessive moisture and direct sunlight. The container should remain tightly closed when not in use to maintain product integrity. Special handling precautions should be taken to ensure that the product is not exposed to extreme temperatures or conditions that may compromise its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for St. Ives, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)